Study of pretransplant conditioning with PK-guided intravenous busulfa
Phase 2
Recruiting
- Conditions
- AML, ALL, MDS, CML, MF, or CMM
- Registration Number
- JPRN-jRCTs051200020
- Lead Sponsor
- Kanda Junya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1) Patients with AML, ALL, MDS, CML, MF, or CMML.
2) Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2.
3) Patients without severe organ dysfunction.
Exclusion Criteria
1) Patients who have a history of allergic reaction to the drugs which are planned to be used in this study.
2) Patients who have underwent hematopoietic stem cell transplantation in the last 12 months.
3) AML or ALL with blasts of 30% or more in the bone marrow or peripheral blood at the registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method